ly dependent on the structural integrity of the glial matrix, would also be distinct. Theoretically, such differences can be detected by analyzing Glu concentrations within the area of edema on proton MR spectoscropy images. Accordingly, we performed proton MR spectroscopy investigations of peritumoral edema using a 3.0-tesla system.
Clinical Material and Methods

Patient and Control Populations
Twenty-three patients with a single brain tumor mass and peritumoral edema and nine healthy individuals participated in this study. The patients harbored several different types of tumors: nine high-grade gliomas (eight men and one woman; age range 54-80 years), eight metastatic brain tumors (five men and three women; age range 48-84 years), and six meningiomas (four men and two women; age range 56-79 years). The tissue type was verified by histopathological assessment of surgical specimens. Two white matter regions, frontal and parietal lobes, were examined in the nine normal control patients. All studies were performed according to the human research guidelines of the internal review board of the University of Niigata. Informed consent was obtained from all individuals.
Proton MR Spectroscopy Studies
A General Electric (GE) Signa LX 3.0-tesla MR imaging system was used to perform all high-field MR imaging studies. A standard head coil with quadrature detection was used. Point-resolved spectroscopic sequence with chemical-shift-selective water suppression was utilized with the following parameters: TR 2 sec; TE 80 msec; data point 2 K; and spectral width 5000 Hz. Using these settings for the 3.0-tesla proton MR spectroscopy, it has been shown that the resonance at 2.35 ppm represents the Glu resonance. 26 Acquisition time was 3.9 minutes per spectrum consisting of 96 signal averages. The region of interest of peritumoral edema was set at the center of the longest line drawn between the borders of Gd-enhanced area (tumor) on T 1 -weighted images and the outer rim of the peritumoral hyperintense area (peritumoral edema) on T 2 -weighted images. In the healthy control individuals, the region of interest was set to include the left frontal and parietal white matter. Postprocessing and spectral analyses were performed using the PROBE/SVQ algorithm and GE's SA/GE spectroscopy package. 21 The areas of representative resonances for NAA, Cho compounds, and Glu were determined by integration and were then normalized to that of the Cr resonance.
Statistical Analysis
The statistical package for the social sciences (SPSS Inc.) was used to perform all statistical analyses. Comparisons of metabolite ratios among three tumor groups were performed using the Kruskal-Wallis test. Values are expressed as means Ϯ standard deviations.
Results
Representative proton MR spectroscopy spectra are shown in Fig. 1 . As with conventional clinical MR spectroscopy, the NAA, Cho, and Cr resonances were clearly resolved in this study. In addition, a resonance at 2.35 ppm was also clearly resolved in all the individuals studied (arrow in Fig. 1 upper right) . For proton MR spectroscopy performed in a 3.0-tesla system with the aforementioned acquisition parameters, it has been previously shown that the resonance at 2.35 ppm represents overwhelmingly the Glu resonance, with only negligible contribution from glutamine or ␥-aminobutyric acid. Accordingly, we assigned this resonance to Glu. 26 Chemical shift assignment is shown in the spectrum of a healthy individual. The resonance for a residue of NAA (asterisk in Fig. 1 ) was not further analyzed. Quantitative analysis of Glu, NAA, and Cho normalized to Cr are shown in Fig. 2 . To correlate previously reported findings based on diffusion tensor imaging, 13 peritumoral edema was categorized into two groups: glial and nonglial tumor. A proton MR spectroscopy neural marker, NAA is significantly reduced in the areas of edema of both glial and nonglial tumors (p Ͻ 0.01), suggesting a reduction in neural components in the region of edema. A marker of membrane metabolism for proton MR spectroscopy, Cho did not show any significant differences among the three groups but demonstrated a higher mean for glial tumor, suggesting an increase in neoplastic activities within the area of edema of glial tumors. The presence of Glu was significantly higher in the nonglial tumor group than in the normal white matter or glial tumor group (p Ͻ 0.01).
Discussion
Glutamate metabolism is stoichiometrically linked to the Glu-glutamine shuttle. 7 Excitation of glutamatergic neurons cause a release of Glu into synaptic clefts. Termination of this glutamatergic neurotransmission relies on specific transporters that clear the synaptic clefts of Glu. Glutamate transporters are present in neurons and astrocytes ensheathing neuronal synapses. There are five subtypes of Glu transporters, designated EAAC1 through EAAC5. Two of these, GLAST (or EAAT-1) and GLT-1(or EAAT-2) are astroglial transporters, whereas the remaining three, EAAC1 (or EAAT-3), EAAT-4, and EAAT-5, are neuronal proteins. 24 Although the function of astroglial Glu transporter subtypes is clear, the role of the neuronal Glu transporter found in cortical structures, EAAC1, has remained elusive. Impairment in expression of two of the glial transporter subtypes (GLAST and GLT-1) causes massive excitotoxicity and neurodegeneration, whereas reduction in the neuronal subtype (EAAC1) is responsible for only mild neurotoxicity, indicating that astrocytic Glu transporters play an essential, if not singular, role in clearing Glu from synaptic clefts. 7, [24] [25] [26] Glutamate is subsequently converted into glutamine in astrocytes. 15 Glutamine is delivered into the extracellular space and enters the neuron to be converted to Glu once again (the so-called Glu-glutamine shuttle). A simplified schematic presentation of the Glu-glutamine shuttle is shown in Fig. 3A .
Optimal functionality of the Glu-glutamine shuttle requires structural integrity of the extracellular glial matrix. 12 In vasogenic edema, the volume of the extracellular space can expand up to 10 times the physiological conditions. 28 Theoretically, therefore, a higher amount of Glu needs to be released from the synaptic button to maintain an equivalent level of Glu transmission as under normal conditions. Indeed, in the cold injury animal model, which is regarded to be a model of pure vasogenic edema, a marked rise in tissue Glu has been observed. 2 A marked increase in synaptic vesicles in deformed dendritic synaptic formation has been demonstrated in clinical cases of vasogenic edema. 1, 3, 5, 6, 8, 30 Given that Glu release is indeed increased in vasogenic edema, accumulation of Glu (and glutamine) within the expanded extracellular space should result. The observed increased in Glu levels of peritumoral edema in the nonglial tumor group shown in this study may indeed reflect this condition (Fig. 3B) .
In contrast to the nonglial tumor group, the glial tumor group in this study was not shown to exhibit a significant increase in Glu in the area of edema. Glioma cells have been shown to infiltrate normal brain tissue and disrupt the structural integrity of the glial matrix. 8, 30 This disruption blocks the efficient cycling of a normal Glu-glutamine shuttle. The authors of several studies have shown that glioma cells have only trace levels of Glu transporter and lack significant glutamine synthetase activity. concentration around implanted C6 glioma cells. 23, 31 Accordingly, it is plausible that impaired glial matrix integrity caused by glioma cell infiltration may result in serious dysfunction of the Glu-glutamine shuttle (Fig. 3C) .
The success of the present study is a direct result of the development of high-field MR imaging systems. Specialized studies, which were once considered to be the domain of research, are now available to be used as routine clinical tools. 9, [18] [19] [20] Proton MR spectroscopy is another product of high-field MR imaging systems. Higher-field systems not only provide a higher signal-to-noise ratio but also allow better chemical shift resolution. Direct proton MR spectroscopy Glu assay represents one of the triumphs of highfield proton MR spectroscopy.
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Conclusions
We have demonstrated that two distinctive types of peritumoral edema, previously identified by differential diffusion characteristics with diffusion tensor imaging, also exhibit characteristic differences in Glu concentration detectable by proton MR spectroscopy. Peritumoral edema of nonglial tumors was found to have significantly higher Glu concentrations compared with peritumoral edema of glial tumors. We hypothesize that this observation may reflect the degree of structural integrity of the glial matrix. FIG. 3 . Schematics of the Glu-glutamine shuttle. A: Normal. Excitation of glutamatergic neurons releases Glu into synaptic clefts. Termination of glutamatergic neurotransmission relies on specific transporters that clear the synaptic cleft. Glutamate transporters are present in neurons (shown as EAAC) and astrocytes ensheathing the synapses (shown as GLT). Under normal conditions, astrocytic Glu transporters play an essential, if not singular, role in clearing Glu out of synaptic clefts. Glutamate is then converted into glutamine, which is delivered into the extracellular space, and enters the neuron to be converted to Glu. B: Peritumoral edema around nonglial tumors. In simple expansion of the synaptic cleft due to vasogenic edema with relatively intact Glu-glutamine shuttle, a compensatory increase in Glu release occurs. Subsequently, Glu accumulation, and to some extent glutamine as well, results within the expanded extracellular space. C: Peritumoral edema around high-grade glioma. Glioma cells infiltrate into normal brain tissue and disrupt the structural integrity of the glial matrix. Because glioma cells have only trace levels of Glu transporter and lack significant glutamine synthetase activity, the Glu concentrations remain low. ATP = adenosine triphosphate; SAT = system A transporter; SN = system N transporter; TCA = tricarboxylic acid cycle.
